Meretoja syndrome: Clinical Trials

2 trials for Meretoja syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Meretoja syndrome: new trials by email Literature Review of Meretoja syndrome trials Research Report on Meretoja syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Presepsin:Gelsolin Ratio in Sepsis-related Organ Dysfunction
Supportive therapy at the ICU, Sepsis therapy, Sepsis-related organ dysfunction therapy - Sepsis, Acute Kidney Injury Due to Sepsis
CompletedUniversity of Pecs1262018-01-012022-04-04
Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels
rhu-pGelsolin, Placebo - Low Gelsolin, Trauma
Phase 1 / Phase 2CompletedCritical Biologics Corporation402008-03-012010-09-29

Narrower conditions

Sepsis (2)  ·  Burns (1)  ·  Infections (1)  ·  Peritonitis (1)  ·  Pneumonia (1)  ·  Respiratory Distress Syndrome (1)  ·  Shock, Septic (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Wounds and Injuries (1)

Broader conditions

Inflammation (2)  ·  Lung Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Shock (2)  ·  Digestive System Diseases (1)  ·  Infections (1)  ·  Intraabdominal Infections (1)  ·  Peritoneal Diseases (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Infections (1)  ·  Systemic Inflammatory Response Syndrome (1)

Sponsors

Critical Biologics Corporation (1)  ·  University of Pecs (1)

Countries

Hong Kong (1)  ·  Hungary (1)

Top investigators

Attila Miseta, MD, Dsc (1)  ·  Richard C Straube, MD (1)  ·  Selene Tam, PhD (1)  ·  Wai M Chan, MBBS (1)

Results publications

PMID 37215727